Comments on design and monitoring of survival trials in complex scenarios
Stat Med
.
2019 Jun 30;38(14):2704.
doi: 10.1002/sim.8087.
Authors
Friederike M-S Barthel
1
,
Abdel Babiker
2
,
Patrick Royston
2
,
Mahesh Kb Parmar
2
Affiliations
1
GlaxoSmithKline, Uxbridge, UK.
2
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
PMID:
31168886
DOI:
10.1002/sim.8087
No abstract available
Publication types
Letter
Comment